Transplant Prognosis in Kidney Transplant Recipients with Diabetes under Mycophenolic Acid-Focused Therapeutic Drug Monitoring
Mycophenolate mofetil is a key immunosuppressant that is metabolized into mycophenolic acid (MPA). The prognostic impact of MPA-focused therapeutic drug monitoring on allograft prognosis has not been determined in kidney transplant recipients with diabetes. In this study, we assessed the pharmacokin...
Guardado en:
Autores principales: | Eisuke Nakamura, Tadashi Sofue, Yasushi Kunisho, Keisuke Onishi, Kazunori Yamaguchi, Emi Ibuki, Rikiya Taoka, Nobufumi Ueda, Mikio Sugimoto, Tetsuo Minamino |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2f26fafbdba94ba98ff9e07d32467697 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Topical mycophenolate mofetil in the treatment of vitiligo: a pilot study
por: Farhad Handjani, et al.
Publicado: (2017) -
Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease
por: ZHANG,TONG, et al.
Publicado: (2009) -
Solid Lipid Nanoparticles of Mycophenolate Mofetil: An Attempt to Control the Release of an Immunosuppressant
por: Iqbal A, et al.
Publicado: (2020) -
Estimation of Mycophenolic Acid Exposure in Heart Transplant Recipients by Population Pharmacokinetic and Limited Sampling Strategies
por: Xipei Wang, et al.
Publicado: (2021) -
Rapid response to mycophenolate mofetil in combination with romiplostim in a case of severe refractory immune thrombocytopenia post COVID‐19 vaccination
por: Snigdha Nutalapati, et al.
Publicado: (2021)